FilingReader Intelligence
Shandong Pharmaceutical Glass faces ownership change via takeover
August 15, 2025 at 05:18 PM UTC•By FilingReader AI
Shandong Pharmaceutical Glass Co announced its controlling shareholder Luzhong Investment received key approvals for reorganization by China National Pharmaceutical Group.
Regulators cleared the acquisition from anti-monopoly review, while authorities approved a 244.9 billion yuan capital increase by China National Pharmaceutical Group and its Hong Kong unit.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SSE:600529•Shanghai Stock Exchange
News Alerts
Get instant email alerts when Shandong Pharmaceutical Glass publishes news
Free account required • Unsubscribe anytime